Pharmaceutical Technology\'s In the Lab eNewsletter-06-05-2019

June 05, 2019

Current practices for cleaning and sterilizing biomanufacturing equipment does not differ much between a multi-product versus single-product setting.

June 05, 2019

The SIMCA 16 software has enhanced functionality features that include usability improvements and increased workflow flexibility.

June 03, 2019

Shimadzu’s C2MAP-2030 system can improve operational efficiency for optimizing and controlling the cell culturing process.

June 03, 2019

Agilent’s updated portfolio of products for immunotherapy researchers provides cell-based tools for translational research and development.

May 31, 2019

Metrohm gains B&W Tek’s line of spectroscopy instruments as well as expertise and facilities.

May 31, 2019

Knauer has introduced new columns and screening services for the enantioseparation of chiral substances.

May 28, 2019

Researchers at the University of Sheffield, Sheffield, UK, have discovered and developed a new compound that can kill antibiotic-resistant bacteria, including Escherichia coli.

May 22, 2019

The guidance discusses the design and evaluation of comparative analytical studies used to support the biosimilarity of a proposed therapeutic protein product to a reference product licensed under section 351(a) of the Public Health Service Act.

May 13, 2019

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), awarded grants totaling $41.6 million to establish four cooperative research centers focused on developing vaccines to prevent sexually transmitted infections (STIs).

May 13, 2019

Harvard University researchers used single-cell sequencing to identify a protein expressed uniquely by insulin-producing beta cells created from stem cells in the laboratory.

May 01, 2019

The companies will join forces to use artificial intelligence (AI) and machine learning to discover and develop new treatments for two chronic diseases.

May 01, 2019

Intertek has announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, UK, through the acquisition of a new 20,000 sq. ft facility.